Skip to search formSkip to main contentSkip to account menu

FCE 26743

Known as: FCE-26743 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

safinamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Target : Monoamine Oxidase Pathway : Neuronal Signaling Solubility : 10 mM in DMSO Caution
  • 2018
  • Corpus ID: 49364862
BIOLOGICAL ACTIVITY: Safinamide (EMD 1195686; FCE 26743) selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits… 
2002
2002
Restorative effects of glutamate antagonists in experimental parkinsonism
Summary. Several compounds with antagonistic actions on N-methyl-D-aspartate (NMDA) receptors were tested for an antiakinesic… 
1999
1999
Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub-/suprathreshold doses of L-Dopa upon motor behaviour of MPTP-treated mice
Summary. The effects of co-administration of the dopamine precursor, L-Dopa, with anticonvulsant and putative anticonvulsive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)